- July 30, 2026
-
Notice Regarding Repricing of Certain Products
- July 28, 2026
-
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognition Registration for Cognitive Health in South Korea
- July 27, 2026
-
Bifidobacteria May Help Suppress Excessive Inflammatory Responses ～Published in the Scientific Journal iScienc～
- July 17, 2026
-
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
- July 09, 2026
-
Morinaga Milk Group’s “Smiles & Health for Children” Program Supporting Kindergarten and Elementary School Meals in Vietnam Wins an Award in the Social Empowerment Category of the Asia Responsible Enterprise Awards 2026, a First for a Japanese Dairy Company.
- July 07, 2026
-
Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient
- July 02, 2026
-
Fourth Phase of the “Smiles & Health for Children” Program Supporting Kindergarten and Elementary School Meals in Vietnam to Begin in July 2026
- June 30, 2026
-
Notice Regarding Repricing of Certain Products
- June 17, 2026
-
Plain Yogurt Containing Bifidobacterium longum BB536, Combined with Lifestyle Improvements, May Slow the Pace of Aging
- June 02, 2026
-
Notice Regarding Suspension of Production and Dissolution of HIROSHIMA MORINAGA MILK INDUSTRY CO., LTD.
